Komori Corporation (6349.T)
JPY 1196.0
(0.34%)
JPY 1196.0
(0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 104.27 Billion | 97.91 Billion | 87.62 Billion | 71.82 Billion | 77.64 Billion | 90.24 Billion |
| Cost of Revenue | 69.69 Billion | 64.17 Billion | 59.59 Billion | 51.47 Billion | 55.39 Billion | 61.96 Billion |
| Gross Profit | 34.58 Billion | 33.74 Billion | 28.02 Billion | 20.35 Billion | 22.25 Billion | 28.27 Billion |
| Operating Expenses | 29.69 Billion | 28.02 Billion | 25.75 Billion | 22.68 Billion | 25.65 Billion | 25.57 Billion |
| Selling, General and Administrative Expenses | 29.68 Billion | 23.94 Billion | 20.26 Billion | 17.55 Billion | 19.53 Billion | 20.11 Billion |
| Research and Development Expenses | 3.73 Billion | 3.65 Billion | 4.05 Billion | 4 Billion | 4.89 Billion | 4.74 Billion |
| Other Expenses | -3.73 Billion | 257 Million | 248 Million | 695 Million | 68 Million | -286 Million |
| Cost and Expenses | 99.38 Billion | 92.19 Billion | 85.35 Billion | 74.15 Billion | 81.05 Billion | 87.53 Billion |
| Operating Income | 4.89 Billion | 5.71 Billion | 2.26 Billion | -2.33 Billion | -3.4 Billion | 2.7 Billion |
| Interest Expense | 102 Million | 64 Million | 58 Million | 51 Million | 7 Million | 52 Million |
| Income Tax Expense | 1.14 Billion | 813 Million | 804 Million | 543 Million | 4.29 Billion | 1.04 Billion |
| Earnings before Tax | 5.8 Billion | 6.6 Billion | 6.99 Billion | -1.52 Billion | -21.17 Billion | 2.45 Billion |
| Net Income | 4.64 Billion | 5.71 Billion | 6.15 Billion | -2.06 Billion | -25.47 Billion | 1.42 Billion |
| Earnings Per Share Basic | 86.78 | 104.85 | 110.67 | -36.98 | -450.10 | 24.51 |
| Earnings Per Share Diluted | 86.78 | 104.85 | 110.67 | -36.98 | -450.10 | 24.51 |
| Weighted Average Shares Outstanding | 53.48 Million | 54.52 Million | 55.64 Million | 55.92 Million | 56.59 Million | 58.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.48 Million | 54.52 Million | 55.64 Million | 55.92 Million | 56.59 Million | 58.22 Million |
| Gross Margin | 0.33 | 0.34 | 0.32 | 0.28 | 0.29 | 0.31 |
| EBIT Margin | 0.07 | 0.09 | 0.07 | 0.02 | -0.01 | 0.05 |
| Profit Margin | 0.04 | 0.06 | 0.07 | -0.03 | -0.33 | 0.02 |
| EBITDA | 7.44 Billion | 8.16 Billion | 4.64 Billion | 775 Million | -18.27 Billion | 4.86 Billion |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.03 | -0.03 | -0.04 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 25.82 Billion | 24.31 Billion | 35.01 Billion | 104.27 Billion | 22.13 Billion | 27.75 Billion |
| Cost of Revenue | 16.97 Billion | 15.64 Billion | 22.86 Billion | 69.69 Billion | 14.63 Billion | 18.94 Billion |
| Gross Profit | 8.84 Billion | 8.67 Billion | 12.14 Billion | 34.58 Billion | 7.5 Billion | 8.81 Billion |
| Operating Expenses | 7.97 Billion | 8.23 Billion | 7.97 Billion | 29.68 Billion | 7.22 Billion | 7.66 Billion |
| Selling, General and Administrative Expenses | 7.97 Billion | 8.22 Billion | 7.97 Billion | - | 6.22 Billion | 6.51 Billion |
| Research and Development Expenses | - | - | 626 Million | - | 999 Million | 1.15 Billion |
| Other Expenses | - | 1 Million | 88 Million | 250 Million | 48 Million | 60 Million |
| Cost and Expenses | 24.95 Billion | 23.87 Billion | 30.83 Billion | 99.37 Billion | 21.85 Billion | 26.61 Billion |
| Operating Income | 864 Million | 442 Million | 4.17 Billion | 4.89 Billion | 282 Million | 1.14 Billion |
| Interest Expense | 37 Million | 26 Million | 33 Million | 102 Million | 26 Million | 20 Million |
| Income Tax Expense | 250 Million | 510 Million | 305 Million | 1.14 Billion | 80 Million | 348 Million |
| Earnings before Tax | 634 Million | 1.13 Billion | 3.66 Billion | 5.8 Billion | 223 Million | 1.47 Billion |
| Net Income | 384 Million | 621 Million | 3.35 Billion | 4.64 Billion | 143 Million | 1.12 Billion |
| Earnings Per Share Basic | 7.24 | 11.70 | 62.82 | - | 2.70 | 21.09 |
| Earnings Per Share Diluted | 7.24 | 11.70 | 62.82 | - | 2.70 | 21.09 |
| Weighted Average Shares Outstanding | 53.05 Million | 53.05 Million | 53.1 Million | 53.48 Million | 53.05 Million | 53.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.05 Million | 53.05 Million | 53.1 Million | 53.48 Million | 53.05 Million | 53.38 Million |
| Gross Margin | 0.34 | 0.36 | 0.35 | 0.33 | 0.34 | 0.32 |
| EBIT Margin | 0.03 | 0.04 | 0.14 | - | 0.01 | 0.05 |
| Profit Margin | 0.01 | 0.03 | 0.10 | 0.04 | 0.01 | 0.04 |
| EBITDA | 682 Million | 1.07 Billion | 4.83 Billion | - | 245 Million | 1.48 Billion |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.12 | 0.05 | 0.01 | 0.04 |
JOHNPHARMA
GML
2125
ASMVF
MAHAPEXLTD
DRMA